Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesothelioma.

McLaren, B R; Whitaker, D; Robinson, B W; Lake, R A

McLaren, B R; Whitaker, D; Robinson, B W; Lake, R A.

Affiliation

McLaren BR; Western Australian Institute for Medical Research, University Department of Medicine, University of Western Australia, Perth, Australia.

Cancer Chemother Pharmacol ; 48(1): 1-8, 2001 Jul.

Article in En | MEDLINE | ID: mdl-11488518

Subject(s)

DNA Topoisomerases, Type II/genetics; Mesothelioma/drug therapy; Adult; Aged; Aged, 80 and over; DNA Topoisomerases, Type II/metabolism; DNA, Complementary/chemistry; Drug Resistance, Neoplasm; Female; Humans; Isoenzymes; Male; Mesothelioma/enzymology; Middle Aged; Mutation; Tumor Cells, Cultured

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA Topoisomerases, Type II / Mesothelioma Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2001 Type: Article Affiliation country: Australia

Search on Google

XML

PubMed Links